December 15, 2023, Inside Medical Liability
MPL Cases: What Are the Primary Drivers of High-Indemnity Medical Malpractice Claims?
Jacqueline Ross, RN, PhD, Coding Director, and Kathrine Soulsby, RN, BSN, Senior Patient Safety Analyst, The Doctors Company, part of TDC Group, investigate high-dollar medical malpractice litigation and explain how reducing diagnostic errors is paramount to enhancing patient safety and mitigating loss costs.
Search
TDC Group Supports Pediatric Cancer Research and Helps Seniors Stay H.O.M.E.
The employees of TDC Group—The Doctors Company, Healthcare Risk Advisors, TDC Specialty Underwriters, and Medical Advantage—consistently demonstrate their generosity to the causes they care most about. Many seek matching funds from the TDC Group Employee Gift Matching Program to double their donations to causes they care about.
The Doctors Company Receives Datos Insights 2025 Impact Award for Insurance Innovation
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has received a 2025 Datos Insights Impact Award for Insurance Innovation. The awards program recognizes organizations that demonstrate excellence in implementing innovative technology solutions that drive measurable business results and industry leadership.
Sep 05, 2025
An Updated Approach to Perioperative Management of Patients Undergoing Noncardiac Surgery: Cleared for Take-Off?
The new guideline for evaluating surgical patients for cardiovascular risk promotes a multidisciplinary approach that can help improve patient outcomes.
From
The Doctor’s Advocate
Fitch Ratings Affirms ‘A’ Ratings, ‘Stable’ Outlook for The Doctors Company
June 30, 2025: Fitch Ratings has affirmed its “A” (Strong) Insurer Financial Strength ratings for The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group. The outlook of these ratings is “Stable.”
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
March 01, 2024, Healthcare Risk Management
AI Creates Liability Risks for Healthcare Organizations
Sue Boisvert, BSN, MHSA, CPPS, CPHRM, DFASHRM, Senior Patient Safety Risk Manager, Department of Patient Safety and Risk Management, The Doctors Company, part of TDC Group, discusses how artificial intelligence (AI) is becoming more common in healthcare, and while it offers substantial benefits, there are serious risks to consider.
Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
Obstetrics and Gynecology: Frequently Asked Patient Safety Questions
Our experts answer questions about topics in obstetrics and gynecology, including cesarean delivery on maternal request and screening mammograms.
The Doctors Company Assists Members Impacted by Hurricane Helene
Due to disruption to member medical practices from Hurricane Helene and consistent with direction from state insurance regulation offices, The Doctors Company will adjust policy cancellation and premium installment due dates for affected members. Premium due dates have generally been extended in Florida, Georgia, North Carolina, South Carolina, and Tennessee, with Florida extending from September 26, 2024, to November 26, 2024.
